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Studies on Lysosomal Enzyme ・in the Cerebrospinal Fluid 
NOB町 OSHITAKASU 
Second Department of Surgery, School of Medicine, Toho University 
(Director : prof. Dr. SABURO AwAzu) 
The activity of the lysosomal enzymes in the cerebrospinal fluid can be hardly deter-
mined by colorimetry if they are not treated anyhow, and some treatment to condensate is 
required. The lysosomal enzymes are characteristically activated by freezing and thawing ; 
as utilizing the property, the cerebrospinal fluid was concentrated by vacuum freeze drying 
method and thus it could be subjected to colorimetric determination. The lysosomal enzymes 
gave very low values of the activity even after the above treatment, and in this experim巴nt
β －glucuronidase was selected and observed in head injury and brain tumor. 
The experimental results were discussed as to (1) fluctuation in the injured brain, (2) 
fluctuation on the onset of various brain tumors, (3) the fluctuation on the value of the 
activity before and after surgical treatment or various combined therapies for the brain 
tumor, and (4) the fluctuation of the value of the activity accompanying the change of the 
pathogenic state in a case, as well as to compare with the values in internal carotid artery 
and internal juglar vein. 
1.β－glucuronidase in the cerebrospinal fluid can be colorimetrical!y determined when the 
fluid is concentrated by vacuum freeze drying method. 
2.β－glucuronidase in the cerebrospinal fluid of patients of head injury show the follow-
ing fluctuation: 
a) Cerebral concussion cases: the value is high in the acute stage after injured, but then 
abruptly decreases to return to the normal level. 
b) Severe cases (Typ巴 IIIand IV of Araki): the value is high in the acute stage after 
injured, and remains at the level for 1 to 2 months. 
3. The values of β－glucuronidase in internal carotid artery and internal juglar vein in 
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patients of head injury were not different. 
4. The activity of β－ghicuronidase in the cerebrospinal fluid of patients of brain tumor 
has a correlation with the activity in the tumor tissue. 
5. The activity of β－glucuronidase in the cerebrospinal fluid of patients of brain tumor 
is high and has a correlation with malignancy of the tumor. It has, however, no correlation 
with the location of the tumor and the appearance of atypical cells in the cerebrospinal 
fluid. 
6. The effect of operation十 combinedtherapy on patients of brain tumor: 
a) The activity of the enzyme is obviously inhibited by 20-50% by DBC-AMP therapy 
and 6°Co irradiation. 
b) 20・30%inhibiting effect is obtained by Bleomycin therapy. 
c) Various combined therapies obviously produce some inhibiting effects, but any of 
them can not decrease the value to a normal level. 
The activity of β－glucuronidase in the cerebrospinal fluid reflects the intracranial 
pathological state, and its determination is significant in clinic, and can be utilized for 









細胞内小器管の 1っとして， lysosomeが存在するこ ている荒木の分類に従L、I, I型の軽症群と， II,IV 
とは古くより報告があったが， lysosomeが注目される 型の重症群に分it，腰椎穿車1］で採取した87例の髄液を












と考えた． ζ 乙では /3-glucuronidaseを対象とし，頭 は測定するまでフリーザー内に密封のまま保存する．
部外傷および脳腫蕩の2疾患をとりあげ検討を行っ 3）β－glucuronidase測定方法






























Fig. 1β’Glucuronidase Activities in CSF on Head Iniury 
Conditions 
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常値まで低下した（Fig.1). 重症群は術前および3病 hrとなお controllζ比し， 50%の増加を示し， 2ケ
日以内に採取した症例は少なかったので， Ci〕受傷直 月までは 0.44μg/ml・CSFhrと徐々に下降の傾向は
後～7病日 (12例）， (i) 8～14病日 (11例）， (ii) 15 あるがなお controlIC比し， 40%の活性値増加が認め
病日～2ヶ月（25例） Iζ分け測定した. 7病日までの られた（Fig.1）.さらに重症群4例を2ヶ月以内lこ軽
値は 0.52pg/ml・CSF/hrと controllζ比し， 65%の 快治癒した群 CAおよびB例）と遷延性昏睡群cお
活性増加を示し， 8～14病日では 0.47pg/ml・CSF, よびD例〉に分けて経時的変化を追求した 軽快治療
Fig. 2β 戸 Glucuronidaseactivity in CSF and Serum on severe head injury 
μg/ml/hr. case A 
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Table 1. ;3・Glucuronidaseactivites in serum on head injury 
Conditions 
0 -7 days (5) 
I. I type 
-14 days (5) 
0 -7 days (28) 

































Table 2. p-Glucuronidase activites in CSF on brain tumor 
Tumor 
astrocytoma grade I -I 









carcinoma of rectum 
carcinoma of stomach 
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glucuronidase測定結果を Table2 IC示す． 脳腫望書
患者の全例Iζ酵素活性上昇を認め， astrocytomaでは
grade I, I の活性値は 0.38pg ml・CSF/hrと220
の増加を示し， gradeIII.IVでは 0.56μg/ml・CSF/
hrと82%の増加を示し，臆努の悪性度と相関が認め
られた.ependymomaの3例は0.33, 0. 47, 0. 701•g ’ 
ml ・CSF/hrであった.pontine glioma 3例は 0.38, 

















0.38, 0.67, 0.84 
0.44 0.78 (0.59〕
0.28, 0.35, 0.47 











た pituitary adenomaの 1.30μg/ml・CSF/hrと高
活性を示した症例は2年前亜全摘手術を受け再発した
ものである． 一方，良性脳騒蕩例では meningiomaが
平均 0.34μg/ml・CSFihr と controllζ比しわずか
















亜全摘出した astrocytomagrade I 1例，試験閉鎖
に終った pontineglioma 1例，全摘および亜全摘出
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Table 3. Effect of DBC-AMP on lysosornal 
enzyme in CSF 
j3-glucuronidase activity 
(μg ml. hr.) 
DBC-AMP DBC-AMP Conditions 
before adrnin. after adrnin. 
astrocytoπla 















Table 4. Effect of Bleomycin on lysosomal 
enzyme in CSF 
Conditions 
astrocytoπla 
grade I (1) 










Table 5. Effect of 6°Co iradiation on lysosomal 




before radiation after radiation 
glioblastoma 0.67 0.53 (4000 rad) multiforme (1) 0.35 (6000 rad) 
ependymoma (1) 0.47 0.48 (4000 rad) 
pinealoma (1) 0.35 0.38 (5400 rad) 
p1tmtary 
adenoma (1) 1.31 
0.41 ( 4000 rad) 
Table 6. Effect of BAR-therapy on lysosomal 
enzyme in CSF 
Conditions 
astrocytoma 
grade I (2) 
astrocytorna 













Table 7. Effect of DBC-AMP and 6°Co irradiation 
therapy on lysosomal enzyme in CSF 
Conditions 
ast；~~a!oma 





before admin. after admin. after 6°Co 
1.24 0.67 0.53 
0.82 0.49 0.45 
0.47 0.41 0.40 
0.42 0.41 0.42 
した convexity,parasagital meningiomaの2例 lζ










;1g1ml ・CSF/hrであった ependymoma,pinealoma 
の症例では活性値変動はみられなかった（Table5). 
(iv) BAR療法例













を投与し， 更に 6oco照射した astrocytomagrade 
II, IV 4例について検討した. DBC-AMP投与前






Fig. 3. A case of glioblastoma multiforme, 47 years old man was administrated 
intermittently DBC-AMP for 8 months. 
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著者らは phenolphtalein nitrophenyl-{3-glucuronide 
を使用し，反応時間の短縮および安定化を計った．










































































































脳腫蕩組織中の lysosome 酵素活性は Allen4> 
Allison5向， Kent18＞，長沢23）らの報告があるが，髄液
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